BRITTANY SEARS: Open Payments
NPI 1477244218 · COEUR D ALENE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,545 in 57 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $760 · 2025 $1,545
Food & beverage: $1,355Education: $190
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 21 | $783 |
| ABBVIE INC. | 12 | $179 |
| UCB, Inc. | 5 | $169 |
| Galderma Laboratories, L.P. | 3 | $68 |
| GENZYME CORPORATION | 3 | $68 |
| Lilly USA, LLC | 3 | $67 |
| Arcutis Biotherapeutics, Inc. | 2 | $30 |
| Amgen Inc. | 1 | $28 |
| Novartis Pharmaceuticals Corporation | 1 | $27 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
Products named: TREMFYA, DUPIXENT, RINVOQ, SKYRIZI, Bimzelx, NEMLUVIO, EBGLYSS, Zoryve.
Industry payments across ID — which companies pay providers there.
